Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism

American Journal of Clinical Nutrition

Volumn 81, Issue 1, 2005, Pages 147-153

  Hobbs, Charlotte A ^a   Cleves, Mario A ^b   Melnyk, Stepan ^b   Zhao, Weizhi ^b   James, S Jill ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

Birth defects; Congenital heart defects; Folate; Homocysteine; Methionine; Risk

Indexed keywords

BIOLOGICAL MARKER; COBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MATERNAL WELFARE; PREGNANCY; RISK FACTOR; SOCIOECONOMICS; BLOOD; NEWBORN; REGISTER; UNITED STATES;

ADULT; ARKANSAS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; HUMANS; INFANT, NEWBORN; LIFE STYLE; METHIONINE; PREGNANCY; REGISTRIES; RISK FACTORS; S-ADENOSYLHOMOCYSTEINE;

EID: 13744256916     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/81.1.147     Document Type: Article

References (48)

1. Botto LD, Correa A. Decreasing the burden of congenital heart anomalies: an epidemiologic evaluation of risk factors and survival. Prog Pediatr Cardiol 2003;18:111-21.
2. Tennstedt C, Chaoui R, Korner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 1999;82:34-9.
3. Botto LD, Mulinare J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet 2003;121A:95-101.
4. Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduce risk for conotruncal heart defects and limb deficiencies among off spring. Am J Med Genet 1995;59:536-45.
5. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 1998;78:151-61.
6. van der Put NM. van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood) 2001;226:243-70.
7. Rosenquist TH, Finnell RH. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 2001;60:53-61.
8. van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 2000;92:57-61.
9. Eskes TK. Open or closed? A world of difference: a history of homocysteine research. Nutr Rev 1998;56:236-44.
10. van Rooij IA, Swinkels DW, Blom HJ, Merkus HM, Steegers-Theunissen RP. Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol 2003;189:1155-60.
11. Kapusta L, Haagmans ML, Steegers EA, Cuypers MH, Blom HJ, Eskes TK. Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 1999;135:773-4.
12. Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001;184:806-17.
13. Raijmakers MT, Roes EM, Zusterzeel PL, Steegers EA, Peters WH. Thiol status and antioxidant capacity in women with a history of severe pre-eclampsia. Br J Obstet Gynaecol 2004;111:207-12.
14. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000;95:519-24.
15. Wong WY, Eskes TK, Kuijpers-Jagtman AM, et al. Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology 1999;60:253-7.
16. Mattson MP, Shea TB. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 2003;26:137-46.
17. Maxwell SR. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol 2000;95:165-71.
18. Cavalca V, Cighetti G, Bamonti F, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001;47:887-92.
19. Wu LL, Wu JT. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 2002;322:21-8.
20. Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-23.
21. Ehrlich M. Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 2003;88:899-910.
22. Finnell RH, Spiegelstein O, Wlodarczyk B, et al. DNA methylation in Fo1bp1 knockout mice supplemented with folic acid during gestation. J Nutr 2002;132:2457S-61S.
23. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep 2001;116:32-40.
24. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990;1:58-64.
25. Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. A new HPLC method for the simultaneous determination of oxidized and reduced plasma aminothiols using coulemetric electrochemical detection. J Nutr Biochem 1999;10:490-7.
26. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5′-phosphate concentrations. Clin Chem 2000;46:265-72.
27. Anderson TW. Darling DA. A test of goodness of fit. J Am Stat Assoc 1954;49:765-9.
28. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley. 2001.
29. Selhub J, Jacques PF, Rosenberg IH, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131:331-9.
30. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Reg 1996;61:8781-97.
31. Centers for Disease Control and Prevention. Folate status in women of childbearing age-United States, 1999. MMWR Morb Mortal Wkly Rep 2000;49:962-5.
32. Than LC, Watkins M, Daniel KL. Serum folate levels among women attending family planning clinics-Georgia. 2000. MMWR Morb Mortal Wkly Rep 2002;51:4-8.
33. Gueant-Rodriguez RM, Rendeli C, Namour B. et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003;344:189-92.
34. De Marco P, Calevo MG, Moroni A, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002;47:319-24.
35. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spinabifida. Mol Genet Metab 1999;67:317-23.
36. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.
37. Nurk E, Tell GS, Vollset SE, et al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 2004;79:812-9.
38. Perna AF, Ingrosso D, Lombardi C, et al. Possible mechanisms of homocysteine toxicity. Kidney Int Suppl 2003;S137-40.
39. Moller P, Wallin H, Knudsen LE. Oxidative stress associated with exercise, psychological stress and life-style factors. Chem Biol Interact 1996;102:17-36.
40. McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology 2002;58:1395-9.
41. Ma J, Stampfer MJ, Christensen B, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:825-9.
42. Ishibashi M, Akazawa S, Sakamaki H, et al. Oxygen-induced embryopathy and the significance of glutathione-dependent antioxidant system in the rat embryo during early organogenesis. Free Radic Biol Med 1997;22:447-54.
43. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69:915-26.
44. Martin CC, Laforest L, Akimenko MA, Ekker M. A role for DNA methylation in gastrulation and somite patterning. Dev Biol 1999;206:189-205.
45. Alonzo-Aperte E, Ubeda N, Achon M, Perez-Miguelsanz J, Varela-Moreias G. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 1999;52:750-6.
46. Cikot RJ, Steegers-Theunissen RP, Thomas CM, de Boo TM, Merkus HM, Steegers EA. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 2001;85:49-58.
47. Walker MC, Smith GN, Perkins SL, Keely EJ, Garner PR. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999;180:660-4.
48. Srivastava S, Gopal-Srivastava R. Biomarkers in cancer screening: a public health perspective. J Nutr 2002;132:2471S-5S.